A randomized controlled phase III multicenter study on dose escalation in definitive chemoradiation for patients with locally advanced esophageal cancer: ARTDECO study.

Maarten C. C. M. Hulshof,Debby Geijsen,Tom Rozema,Vera Oppedijk,Jeroen Buijsen,Karen J. Neelis,Joost J. Nuyttens,Maurice J.C. van der Sangen,Paul M. Jeene,Janny G. Reinders,Mark I. van Berge Henegouwen,Jeanin E. van Hooft,Hanneke W. M. van Laarhoven,Ate van der Gaast

A randomized controlled phase III multicenter study on dose escalation in definitive chemoradiation for patients with locally advanced esophageal cancer: ARTDECO study.

2020

Maarten C. C. M. Hulshof
Debby Geijsen
Tom Rozema
Vera Oppedijk
Jeroen Buijsen
Karen J. Neelis
Joost J. Nuyttens
Maurice J.C. van der Sangen
Paul M. Jeene
Janny G. Reinders
Mark I. van Berge Henegouwen
Jeanin E. van Hooft
Hanneke W. M. van Laarhoven
Ate van der Gaast

281Background: To analyze the effect of radiation dose escalation to the primary tumor on local control, locoregional control, survival and toxicity in definitive chemoradiation for esophageal canc...

Keywords:

dose escalation
Internal medicine
Physical therapy
Esophageal cancer
Medicine
multicenter study
Oncology
Primary tumor
Toxicity
locally advanced
radiation dose
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations